The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTILS.L Share News (TILS)

  • There is currently no data for TILS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AIM WINNERS & LOSERS: Tiziana plans switch to US; Vertu ups guidance

Fri, 20th Aug 2021 11:13

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Friday.

----------

AIM - WINNERS

----------

Remote Monitored Systems PLC, up 25% at 0.75 pence, 12-month range 0.36p-5.00p. Reports new Anglo-Indian partnership between its subsidiary Pharm 2 Farm Ltd and India's VKE Enterprises to distribute its Pro-Larva mask. The London-based survey and inspection services provider says Pro-Larva mask is the first anti-viral mask to be approved by the UK Medicines & Healthcare Products Regulatory Agency as a class 1 medical device. The Pro-Larva face mask is made in Britain using patented a-Virion nanotechnology that is clinically proved to kill 99.9% of Covid and Influenza viruses, within 5 minutes of contact, and continues to kill the virus for seven hours, RMS says.

----------

Vertu Motors PLC, up 7.6% at 50.80 pence, 12-month range 24.40p-50.60p. Sees strong used vehicle gross margin retention, due to "exceptional" UK used car market conditions. As a result, expects adjusted pretax profit of no less than GBP50 million in year to August 31, upped from previous guidance between GBP40 million to GBP45 million. "The group's like-for-like new vehicle order take for the key month of September is currently running in excess of prior year levels, however, there is a risk that well documented new vehicle supply shortages will result in vehicle deliveries being delayed into future periods. As a consequence of reduced new vehicle supply, used vehicle supply may also be restricted in the coming months," company adds.

----------

AIM - LOSERS

----------

Amur Minerals Corp, down 11% at 2.18 pence, 12-month range 1.30p-2.90p. Notes permanent conditions report on its far east Russia Kun-Manie nickel copper sulfide project completed. It shows the nickel cutoff grade is calculated to be 0.3% nickel. Revenue is based on a presently conservative nickel price of USD13,300 per tonne and a copper price of USD5,960 per tonne. Metal recoveries are anticipated to be 74% for nickel and 52% for copper. Mine ore production and the nominal mill throughput at six million tonnes per annum indicates a potential mine life in the order of 25 years. The report says the reserve base is substantial and suitable to potentially sustain an 11.2 million tonne per year throughput

----------

Tiziana Life Sciences PLC, down 12% at 51.08 pence, 12-month range 51.08p-204.00p. Formally starts strategic plan to change its corporate structure by establishing Tiziana Life Sciences Ltd, a Bermuda-incorporated company, as the ultimate parent company of the Tiziana group. Shares will be swapped for shares in the new parent company, which will then be listed in the US on Nasdaq. As a result, Tiziana to be delisted in London. "The interests of its business and shareholders are best served by aligning the place of the listing with the principal business activities of the Tiziana group, which are predominately based in the US," company explains.

----------

By Paul McGowan; paulmcgowan@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
27 Apr 2020 09:43

Tiziana Life Sciences files for patent on potential Covid-19 therapy

(Sharecast News) - Biotechnology company Tiziana Life Sciences has filed a provisional patent application on the combination of nanoparticle-Actinomycin D (NP-ACT D) with anti-interleukin-6 receptor monoclonal antibody (anti-IL-6R), it announced on Monday, as a potential therapy for the management of Covid-19 disease.

Read more
24 Apr 2020 18:39

Tiziana Life Sciences Acquires Potential Covid-19 Treatment Medication

Tiziana Life Sciences Acquires Potential Covid-19 Treatment Medication

Read more
9 Apr 2020 11:23

UK WINNERS & LOSERS SUMMARY: Lockdowns Lift Just Eat Takeaway Orders

UK WINNERS & LOSERS SUMMARY: Lockdowns Lift Just Eat Takeaway Orders

Read more
9 Apr 2020 09:12

Tiziana Life Sciences Shares Double On Covid-19 Treatment News

Tiziana Life Sciences Shares Double On Covid-19 Treatment News

Read more
9 Apr 2020 08:03

LONDON BRIEFING: Bank Of England Extends UK Government's Overdraft

LONDON BRIEFING: Bank Of England Extends UK Government's Overdraft

Read more
16 Mar 2020 17:48

Tiziana Raises USD10 Million To Help Fund Covid-19 Drug Development

Tiziana Raises USD10 Million To Help Fund Covid-19 Drug Development

Read more
12 Mar 2020 14:31

Tiziana Secures USD10 Million To Help Coronavirus Antibody Development

Tiziana Secures USD10 Million To Help Coronavirus Antibody Development

Read more
11 Mar 2020 12:15

Tiziana Life Sciences expediting development of Covid-19 drug

(Sharecast News) - Tiziana Life Sciences said on Wednesday that it is expediting the development of a drug that could help in the treatment of people infected with Covid-19.

Read more
11 Mar 2020 10:51

Tiziana Shares Skyrocket On Expedited Covid-19 Treatment Development

Tiziana Shares Skyrocket On Expedited Covid-19 Treatment Development

Read more
17 Feb 2020 14:30

Tiziana Life Sciences Proposes ADS Offering On Nasdaq

Tiziana Life Sciences Proposes ADS Offering On Nasdaq

Read more
4 Feb 2020 13:26

DIRECTOR DEALINGS SUMMARY: Biffa Municipal MD Sells 154,000 Shares

DIRECTOR DEALINGS SUMMARY: Biffa Municipal MD Sells 154,000 Shares

Read more
21 Jan 2020 16:09

Tiziana Life Sciences Hires OKYO Pharma Director MacRae As Non-Exec

Tiziana Life Sciences Hires OKYO Pharma Director MacRae As Non-Exec

Read more
14 Jan 2020 14:42

DIRECTOR DEALINGS: Tiziana Life Says Associate Of Chair Bought Shares

DIRECTOR DEALINGS: Tiziana Life Says Associate Of Chair Bought Shares

Read more
13 Jan 2020 11:07

Tiziana Life Science To Cancel AIM Trading Ahead Of Move To Bermuda

Tiziana Life Science To Cancel AIM Trading Ahead Of Move To Bermuda

Read more
9 Jan 2020 12:21

Tiziana Says Antibody Foralumab "Well Tolerated" At All Doses Tested

Tiziana Says Antibody Foralumab "Well Tolerated" At All Doses Tested

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.